Treat and repeat: oncolytic virus therapy for brain cancer
- PMID: 35864255
- DOI: 10.1038/s41591-022-01901-4
Treat and repeat: oncolytic virus therapy for brain cancer
Comment on
-
Intratumoral oncolytic herpes virus G47∆ for residual or recurrent glioblastoma: a phase 2 trial.Nat Med. 2022 Aug;28(8):1630-1639. doi: 10.1038/s41591-022-01897-x. Epub 2022 Jul 21. Nat Med. 2022. PMID: 35864254 Free PMC article. Clinical Trial.
References
-
- Bagley, S. J. et al. Clin. Cancer Res. 28, 594–602 (2022). - DOI
-
- Milano, M. T. et al. Int. J. Radiat. Oncol. Biol. Phys. 78, 1147–1155 (2010). - DOI
-
- Todo, T. et al. Nat. Med. https://doi.org/10.1038/s41591-022-01897-x (2022). - DOI - PubMed
-
- Wheeler, L. A. et al. Neuro-Oncology 18, 1137–1145 (2016). - DOI
-
- Chiocca, E. A., Nassiri, F., Wang, J., Peruzzi, P. & Zadeh, G. Neuro-Oncology 21, 14–25 (2019). - DOI
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
